272 related articles for article (PubMed ID: 28177909)
1. Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.
Wang T; Wang M; Fang S; Wang Q; Fang R; Chen J
Oncotarget; 2017 Mar; 8(12):18991-19012. PubMed ID: 28177909
[TBL] [Abstract][Full Text] [Related]
2. Fibulin-3 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition and activating the Wnt/β-catenin signaling pathway.
Wang S; Zhang D; Han S; Gao P; Liu C; Li J; Pan X
Sci Rep; 2017 Jul; 7(1):6215. PubMed ID: 28740094
[TBL] [Abstract][Full Text] [Related]
3. EFEMP1 is repressed by estrogen and inhibits the epithelial-mesenchymal transition via Wnt/β-catenin signaling in endometrial carcinoma.
Yang T; Zhang H; Qiu H; Li B; Wang J; Du G; Ren C; Wan X
Oncotarget; 2016 May; 7(18):25712-25. PubMed ID: 27015552
[TBL] [Abstract][Full Text] [Related]
4. Fibulin-4 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition via the PI3K/Akt/mTOR pathway.
Zhang D; Wang S; Chen J; Liu H; Lu J; Jiang H; Huang A; Chen Y
Int J Oncol; 2017 May; 50(5):1513-1530. PubMed ID: 28339091
[TBL] [Abstract][Full Text] [Related]
5. Fibulin-3 knockdown inhibits cervical cancer cell growth and metastasis in vitro and in vivo.
Li J; Qi C; Liu X; Li C; Chen J; Shi M
Sci Rep; 2018 Jul; 8(1):10594. PubMed ID: 30006571
[TBL] [Abstract][Full Text] [Related]
6. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
[TBL] [Abstract][Full Text] [Related]
7. TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway.
Sun J; Zhang T; Cheng M; Hong L; Zhang C; Xie M; Sun P; Fan R; Wang Z; Wang L; Zhong J
J Exp Clin Cancer Res; 2019 Feb; 38(1):104. PubMed ID: 30813948
[TBL] [Abstract][Full Text] [Related]
8. Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC.
Ren XY; Zhou GQ; Jiang W; Sun Y; Xu YF; Li YQ; Tang XR; Wen X; He QM; Yang XJ; Liu N; Ma J
Cancer Prev Res (Phila); 2015 Oct; 8(10):968-77. PubMed ID: 26276746
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA steroid receptor activator promotes the progression of endometrial cancer via Wnt/ β-catenin signaling pathway.
Park SA; Kim LK; Kim YT; Heo TH; Kim HJ
Int J Biol Sci; 2020; 16(1):99-115. PubMed ID: 31892849
[No Abstract] [Full Text] [Related]
10. Fibulin-3 suppresses Wnt/β-catenin signaling and lung cancer invasion.
Chen X; Meng J; Yue W; Yu J; Yang J; Yao Z; Zhang L
Carcinogenesis; 2014 Aug; 35(8):1707-16. PubMed ID: 24480807
[TBL] [Abstract][Full Text] [Related]
11. PRRX1 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer.
Guo J; Fu Z; Wei J; Lu W; Feng J; Zhang S
Med Oncol; 2015 Jan; 32(1):393. PubMed ID: 25428393
[TBL] [Abstract][Full Text] [Related]
12. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
[TBL] [Abstract][Full Text] [Related]
13. EFEMP2 suppresses epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human bladder cancer.
Zhou Q; Chen S; Lu M; Luo Y; Wang G; Xiao Y; Ju L; Wang X
Int J Biol Sci; 2019; 15(10):2139-2155. PubMed ID: 31592144
[TBL] [Abstract][Full Text] [Related]
14. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
Chen H; Wang Y; Xue F
Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of fibulin-4 is associated with tumor progression and poor prognosis in patients with cervical carcinoma.
Chen J; Zhang J; Liu X; Fang R; Zhao Y; Ma D
Oncol Rep; 2014 Jun; 31(6):2601-10. PubMed ID: 24737201
[TBL] [Abstract][Full Text] [Related]
16. HMGB1 is negatively correlated with the development of endometrial carcinoma and prevents cancer cell invasion and metastasis by inhibiting the process of epithelial-to-mesenchymal transition.
Luan X; Ma C; Wang P; Lou F
Onco Targets Ther; 2017; 10():1389-1402. PubMed ID: 28424555
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt/β-catenin/ZEB1 signaling.
Qu J; Li M; An J; Zhao B; Zhong W; Gu Q; Cao L; Yang H; Hu C
Int J Oncol; 2015 Dec; 47(6):2141-52. PubMed ID: 26459797
[TBL] [Abstract][Full Text] [Related]
18. [Effect of miR1290 on the growth of endometrial cancer and the related mechanism].
Shen XC; Sun YQ; Yan L; Zhao XX
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):130-138. PubMed ID: 35184456
[No Abstract] [Full Text] [Related]
19. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition.
Wen Y; Tan X; Wu X; Wu Q; Qin Y; Liang M; Ran G; Gu H; Xie R
Cancer Biomark; 2019; 26(1):21-30. PubMed ID: 31322544
[TBL] [Abstract][Full Text] [Related]
20. KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways.
Yang M; Han YM; Han Q; Rong XZ; Liu XF; Ln XY
J Cell Mol Med; 2021 Oct; 25(19):9411-9426. PubMed ID: 34453479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
